Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain

Metabolic Brain Disease

Volumn 30, Issue 4, 2015, Pages 1035-1041

  Ahmadi, Shamseddin ^a   Poureidi, Mahsa ^a   Rostamzadeh, Jalal ^a  

^a UNIVERSITY OF KURDISTAN   (Iran)

Author keywords

Bile duct ligation; Chronic liver failure; Gene expression; Nociception

Indexed keywords

AMMONIA; BILIRUBIN; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NMDA RECEPTOR A1; PROTEIN SUBUNIT;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; BIOCHEMICAL ANALYSIS; COMMON BILE DUCT; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; GLUN1 GENE; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PREFRONTAL CORTEX; QUANTITATIVE ANALYSIS; RAT; RAT MODEL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; BRAIN; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN SUBUNIT; WISTAR RAT;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HEPATIC ENCEPHALOPATHY; MALE; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84943353465     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-015-9669-x     Document Type: Article

References (43)

1. Adler RD, Wannagat FJ, Ockner RK (1977) Bile secretion in selective biliary obstruction. Adaptation of taurocholate transport maximum to increased secretory load in the rat. Gastroenterology 73: 129-136.
2. Ahmadi S, Karami Z, Mohammadian A, Khosrobakhsh F, Rostamzadeh J (2015) Cholestasis induced antinociception and decreased gene expression of MOR1 in rat brain. Neuroscience 284: 78-86.
3. Alemi F et al (2013) The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest 123: 1513-1530.
4. Benedetti A et al (1997) Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology 26: 9-21.
5. Bergasa NV, Sabol SL, Young WS 3rd, Kleiner DE, Jones EA (1995) Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 268: G346-G354.
6. Butterworth RF (2008) Pathophysiology of hepatic encephalopathy: the concept of synergism. Hepatol Res 38(Suppl 1): S116-S121.
7. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT (2009) Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29: 783-788.
8. Cauli O, Mansouri MT, Agusti A, Felipo V (2009a) Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 136: 1359-1367, e1351-1352.
9. Cauli O et al (2009b) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis 24: 69-80.
10. Cauli O et al (2014) Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain. Neuromol Med 16: 360-375.
11. Chiu K, LauWM, Lau HT, So KF, Chang RC (2007) Micro-dissection of rat brain for RNA or protein extraction from specific brain region. J Vis Exp 7: 269.
12. Da Silva LF, Walder RY, Davidson BL, Wilson SP, Sluka KA (2010) Changes in expression of NMDA-NR1 receptor subunits in the rostral ventromedial medulla modulate pain behaviors. Pain 151: 155-161.
13. Felipo V (2013) Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci 14: 851-858.
14. Garcia-Ayllon MS et al (2008) Brain cholinergic impairment in liver failure. Brain 131: 2946-2956.
15. Glasgow NG, Siegler Retchless B, Johnson JW (2015) Molecular bases ofNMDAreceptor subtype-dependent properties. J Physiol 593: 83-95.
16. Hasanein P, Parviz M, Keshavarz M, Javanmardi K, Allahtavakoli M, Ghaseminejad M (2007) Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate. Eur J Pharmacol 554: 123-127.
17. Huang LT, Hsieh CS, Chou MH, Chuang JH, Liou CW, Tiao MM, Lai MC (2004) Obstructive jaundice in rats: cause of spatial memory deficits with recovery after biliary decompression. World J Surg 28: 283-287.
18. Incontro S, Asensio CS, Edwards RH, Nicoll RA (2014) Efficient, complete deletion of synaptic proteins using CRISPR. Neuron 83: 1051-1057.
19. Jayanthi S et al (2014) Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms. Biol Psychiatry 76: 47-56.
20. Keil GJ 2nd, Delander GE (1995) Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J Pharmacol Exp Ther 274: 1387-1392.
21. LlansolaMet al (2013) Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations. Metab Brain Dis 28: 151-154.
22. Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, Butterworth RF (2004) Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 40: 742-748.
23. Magen I, AvrahamY, Ackerman Z, Vorobiev L, MechoulamR, BerryEM (2009) Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 51: 528-534.
24. Maillette de Buy Wenniger L, Beuers U (2010) Bile salts and cholestasis. Dig Liver Dis 42: 409-418.
25. Marone M, Mozzetti S, De Ritis D, Pierelli L, Scambia G (2001) Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online 3: 19-25.
26. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals (2011) Guide for the care and use of laboratory animals. 8th edition. National Academies Press (US), Washington (DC).
27. Nicoll J, Axiotis CA, Bergasa NV (2005) The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses 65: 1099-1105.
28. Olde Damink SW, Jalan R, Dejong CH (2009) Interorgan ammonia trafficking in liver disease. Metab Brain Dis 24: 169-181.
29. Ossipov MH, Harris S, Lloyd P, Messineo E, Lin BS, Bagley J (1990) Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 73: 1227-1235.
30. Paoletti P (2011)Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33: 1351-1365.
31. Paoletti P, Neyton J (2007) NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 7: 39-47.
32. Piovesan EJ et al (2008) Influence of NMDA and non-NMDA antagonists on acute and inflammatory pain in the trigeminal territory: a placebo control study. Arq Neuropsiquiatr 66: 837-843.
33. Priya A, Johar K, Wong-Riley MT (2013) Specificity protein 4 functionally regulates the transcription of NMDA receptor subunits GluN1, GluN2A, and GluN2B. Biochim Biophys Acta 1833: 2745-2756.
34. Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V (2010) Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139: 675-684.
35. Rodriguez-Garay EA (2003) Cholestasis: human disease and experimental animal models. Ann Hepatol 2: 150-158.
36. Rodriguez-Munoz M, Sanchez-Blazquez P, Vicente-Sanchez A, Berrocoso E, Garzon J (2012) The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology 37: 338-349.
37. Rousseaux C (2008) A review of glutamate receptors I: current understanding of their biology. J Toxicol Pathol 21: 25-21.
38. Sanz-Clemente A, Nicoll RA, Roche KW (2013) Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist Rev J Neurobiol Neurol Psychiatry 19: 62-75.
39. Tian Q et al (2004) Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics MCP 3: 960-969.
40. Vogels BA, Maas MA, Daalhuisen J, Quack G, Chamuleau RA (1997) Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 25: 820-827.
41. Wen S, Schroeter A, Klocker N (2013) Synaptic plasticity in hepatic encephalopathy-a molecular perspective. Arch Biochem Biophys 536: 183-188.
42. Wright G et al. (2010) Role of aquaporin-4 in the development of brain oedema in liver failure. J Hepatol 53: 91-97.
43. Zhou HY, Chen SR, Pan HL (2011) Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain. Expert Rev Clin Pharmacol 4: 379-388.